We are live on
!
Find out more
Summit Therapeutics
SMMT
SMMT
212 hedge funds and large institutions have $1.91B invested in Summit Therapeutics in 2025 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more funds holding
Funds holding: 204 → 212 (+8)
0.83% more ownership
Funds ownership: 12.56% → 13.39% (+0.83%)
31% less call options, than puts
Call options by funds: $45.5M | Put options by funds: $65.7M
Holders
212
Holding in Top 10
3
Calls
$45.5M
Puts
$65.7M
Top Buyers
| 1 | +$26.4M | |
| 2 | +$25.7M | |
| 3 | +$25.6M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$18.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.3M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$15.1M | |
| 3 | -$6.76M | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$4.48M |
| 5 |
BCM
Boxer Capital Management
San Diego,
California
|
-$4.46M |